Patients under photochemotherapy are generally not given other photosensitizing agents for the duration of this therapy. Beside that, are there other drugs which could lead to incompatibility with 8-MOP?
Jung, E.G.
Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 29(12): 671
1978
ISSN/ISBN: 0017-8470 PMID: 721477 Document Number: 131792
Document emailed within 1 workday
Related Documents
Shakhtmeĭster, I.I.; Pisarenko, M.F.; Kaukhova, O.I.; Shablinskaia, E.M.; Bazarov, B.P. 1982: External use of photosensitizing agents in PUVA therapy of dermatoses Vestnik Dermatologii i Venerologii 11: 13-15Zhang, G.W. 1983: Treatment of psoriasis by photochemotherapy: a comparison between the photosensitizing capsule of Angelica dahurica and 8-MOP Zhonghua Yi Xue Za Zhi 63(1): 16-19
Mørk, N.J.; Braathen, L.R.; Rajka, G.; Hoel, P.S. 1988: Photochemotherapy and skin cancer. the occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(8-9): 676-678
Lacour, J.P. 2002: Phototherapy and photosensitizing agents Annales de Dermatologie et de Venereologie 129(3): 356-357
Przybilla, B.; Ring, J.; Schwab, U.; Galosi, A.; Dorn, M.; Braun-Falco, O. 1987: Photosensitizing properties of nonsteroidal antirheumatic drugs in the photopatch test Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 38(1): 18-25
Schenck, E.G.; Kirchert, W. 1978: The "paired cards" system. A practical and generally applicable procedure for the clinical trial of drugs Arzneimittel-Forschung 28(1a): 192
Chubarev, V.N. 1990: The incompatibility of antihistamine preparations with other drug agents Meditsinskaia Sestra 49(6): 43-48
Averbeck, D.; Dubertret, L.; Craw, M.; Truscott, T.G.; Dall'Acqua, F.; Rodighiero, P.; Vedaldi, D.; Land, E.J. 1984: Photophysical, photochemical and photobiological studies of 4'-methylangelicins, potential agents for photochemotherapy Il Farmaco; Edizione Scientifica 39(1): 57-69
Shea, C.R.; Chen, N.; Wimberly, J.; Hasan, T. 1989: Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells Cancer Research 49(14): 3961-3965
Hvidberg, E.; Bols, T.; Jacobsen, N. 1973: Incompatibility and other problems in adding drugs to intravenous fluids Ugeskrift for Laeger 135(24): 1221-1229
Ronda Beltrán, J.; Chuliá Campos, V. 1971: Physicochemical type incompatibility of the most common drugs used in anesthesia and resuscitation Revista Espanola de Anestesiologia y Reanimacion 18(4): 564-567
Sindrup, S.H. 1990: Drug therapy of symptoms in peripheral diabetic neuropathy. Tricyclic antidepressive agents and other drugs Ugeskrift for Laeger 152(8): 554-556
Haberman, H.F. 1995: Photochemotherapy of rheumatoid arthritis--will this be a new therapy Journal of Rheumatology 22(1): 3-4
Lynch, W.S.; Roenigk, H.H. 1977: Essentials for PUVA therapy. Guidelines for photochemotherapy Cutis 20(4): 494-501
Yang, Y.; Jiang, L.; Liu, Q.; Wang, G.; Chen, Y.; Wan, T. 2014: Duration of speech therapy in patients with or without velopharyngeal insufficency after palatoplasty Zhonghua Kou Qiang Yi Xue Za Zhi 49(12): 715-718
Hofmann, C.; Plewig, G.; Braun-Falco, O. 1976: Clinical experience with the 8-methoxypsoralen-UVA therapy (photochemotherapy) of psoriasis Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 27(12): 588-594
Mundo, A.; Pedone, V.; Lamanna, G.; Cervini, C. 1997: Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis La Clinica Terapeutica 148(1-2): 7-13
Cory-Slechta, D.A. 1990: Exposure duration modifies the effects of low level lead of fixed-interval performance Neurotoxicology 11(3): 427-441
Bell, P.F.; Mirakhur, R.K.; Elliott, P. 1989: Onset and duration of clinical relaxation of atracurium and vecuronium in patients on chronic nifedipine therapy European Journal of Anaesthesiology 6(5): 343-346
Iser, J.H.; Buttigieg, R.J.; Iseli, A. 1994: Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer Medical Journal of Australia 160(4): 192-196